Pro-Dex Corp (PDEX): Utang-utang marang kapitalisasi buku

Tandha merek Pro-Dex Inc (PDEX)

Pro-Dex, Inc. (PDEX) minimizes risks through contract manufacturing of power tools, although growing hospital demand for equipment upgrades is putting pressure on resources. The current debt-to-equity ratio resolves this dissonance, where 0.38 determines the current value of the financial stability indicator. Long-term B2B contracts with medical behemoths guarantee a stable cash flow and high-quality earnings.

PDEX (Pro-Dex Inc.) riwayat Utang marang nilai buku saka 04.07.2022 nganti 27.10.2026
Produk asli Pro-Dex Inc.

Steady demand for Pro-Dex, Inc. (PDEX) surgical equipment forms the foundation for analyzing debt sustainability. This metric compares total liabilities to the book value of equity to determine the degree of financial leverage. By analyzing this debt-to-equity chart, an investor can identify default risks or excessive conservatism. A declining ratio confirms asset protection, although a sharp drop may signal investment stagnation. This price action verifies the quality of earnings within the defensive medical sector.

Karo sapa Pro-Dex, Inc. saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Zentek Limited ZTEK|Rasio utang marang nilai buku Elutia Corporation ELUT|Utang marang nilai buku Milestone Scientific (MLSS)|nexgel.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku RVP (Retractable Tech)|HBIO: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Femasys Corp (FEMY)|MHUA (Meihua Medical Technologies Co., Ltd.) - Rasio utang-utang marang kapitalisasi buku|POAI - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik CJMB|Atrion - Rasio utang marang kapitalisasi buku|Utang-utang marang nilai buku NeuroMetrix Inc NURO